Alkermes PLC | Mutual Funds
Mutual Funds that own Alkermes PLC
Fidelity Growth Company Fund
9,225,707
5.94%
-158,946
0.85%
07/31/2018
Vanguard Health Care Fund
8,990,310
5.79%
175,934
0.8%
06/30/2018
PRIMECAP Odyssey Growth Fund
7,644,747
4.92%
944,900
2.54%
06/30/2018
Vanguard Capital Opportunity Fund
6,687,863
4.3%
0
1.59%
06/30/2018
PRIMECAP Odyssey Aggressive Growth Fund
6,214,822
4%
234,000
2.47%
06/30/2018
T Rowe Price Mid Cap Growth Fund
6,000,000
3.86%
250,000
0.82%
06/30/2018
Vanguard Total Stock Market Index Fund
3,894,814
2.5%
19,050
0.02%
07/31/2018
Vanguard Mid Cap Index Fund
3,679,779
2.37%
29,039
0.16%
07/31/2018
T Rowe Price Mid Cap Value Fund
3,059,427
1.97%
580,700
1%
06/30/2018
Invesco Perpetual UK Invt. Ser. - High Income
2,994,037
1.93%
-360,134
1.09%
03/29/2018
| Address |
Connaught House
Dublin Dublin D04 C5Y6
Ireland
|
|
Employees
|
- |
| Website |
http://www.alkermes.com |
| Updated |
07/08/2019 |
| Alkermes Plc IS a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. It operates through the following geographical segments: U. S. |
